INT131: Completed Phase IIb enrollment

InteKrin completed enrollment of 372 patients in a double-blind, placebo-controlled, U.S. and Mexican Phase IIb trial (INT131-007) evaluating 4 dosages of oral INT131 given once daily vs. Actos piogl...